Literature DB >> 1971420

Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.

E Di Marco1, J H Pierce, C L Knicley, P P Di Fiore.   

Abstract

While the normal human erbB-2 gene is potently transforming when overexpressed in NIH 3T3 cells, its rat homolog, the neu gene, seems to acquire transforming properties only upon alteration of its coding sequence. In this study, we compared the effects of different levels of expression of normal erbB-2 and neu in NIH 3T3 cells. Our results revealed that the normal rat neu gene acts as a potent oncogene when sufficiently overexpressed in NIH 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1971420      PMCID: PMC360691          DOI: 10.1128/mcb.10.6.3247-3252.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Purification of the catalytically active phosphorylated form of insulin receptor kinase by affinity chromatography with O-phosphotyrosyl-binding antibodies.

Authors:  D T Pang; B R Sharma; J A Shafer
Journal:  Arch Biochem Biophys       Date:  1985-10       Impact factor: 4.013

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.

Authors:  P P Di Fiore; O Segatto; F Lonardo; F Fazioli; J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

5.  Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas.

Authors:  L C Padhy; C Shih; D Cowing; R Finkelstein; R A Weinberg
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

6.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Authors:  R C Mulligan; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

Authors:  C R King; M H Kraus; S A Aaronson
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

8.  A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.

Authors:  K Semba; N Kamata; K Toyoshima; T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

10.  Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.

Authors:  C Shih; L C Padhy; M Murray; R A Weinberg
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

View more
  22 in total

1.  Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.

Authors:  L Lehtola; M Nistér; E Hölttä; B Westermark; K Alitalo
Journal:  Cell Regul       Date:  1991-08

2.  Identification and characterization of a novel enhancer for the rat neu promoter.

Authors:  D H Yan; M C Hung
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Protein quantification from complex protein mixtures using a proteomics methodology with single-cell resolution.

Authors:  H T Zhang; J E Kacharmina; K Miyashiro; M I Greene; J Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice.

Authors:  Laura Masuelli; Laura Marzocchella; Chiara Focaccetti; Florigio Lista; Alessandra Nardi; Antonio Scardino; Maurizio Mattei; Mario Turriziani; Mauro Modesti; Guido Forni; Jeffrey Schlom; Andrea Modesti; Roberto Bei
Journal:  Cancer Immunol Immunother       Date:  2010-04-04       Impact factor: 6.968

Review 5.  Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.

Authors:  Elizabeth A Fry; Pankaj Taneja; Kazushi Inoue
Journal:  Int J Cancer       Date:  2016-09-12       Impact factor: 7.396

6.  Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Authors:  C T Guy; M A Webster; M Schaller; T J Parsons; R D Cardiff; W J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.

Authors:  A Roetger; A Merschjann; T Dittmar; C Jackisch; A Barnekow; B Brandt
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 8.  Calcium-mediated signal transduction: biology, biochemistry, and therapy.

Authors:  K Cole; E Kohn
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

9.  Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.

Authors:  S M Jong; C S Zong; T Dorai; L H Wang
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.

Authors:  J M Bosher; T Williams; H C Hurst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.